QUINACRINE (ATABRINE) IN TREATMENT OF NEOPLASTIC EFFUSIONS

[1] ACKERMAN NB, 1964, JAMA-J AM MED ASSOC, V187, P832

[2] BRILMAYER C, 1955, Z Krebsforsch, V60, P334, DOI 10.1007/BF00631687

[3] CLARKSON B, 1964, CANCER-AM CANCER SOC, V17, P914, DOI 10.1002/1097-0142(196407)17:7<914::AID-CNCR2820170712>3.0.CO

[4] 2-6

[5] GELLHORN A, 1961, DIS CHEST, V39, P165

[6] GOODMAN LS, 1956, PHARMACOL BASIS, P1167

[7] INHIBITION OF ENZYMES BY ATEBRIN [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1960, 44 (01) : 175 - 177

[8] HIRSCHBERG E, 1956, P AM ASSOC CANC RES, V2, P117

[9] SELECTION OF PATIENTS FOR EVALUTATION OF CHEMOTHERAPEUTIC PROCEDURES IN ADVANCED CANCER [J]. JOURNAL OF CHRONIC DISEASES, 1962, 15 (MAR): : 243 - &

[10] KURNICK NB, 1962, J LAB CLIN MED, V60, P669

[1] ACKERMAN NB, 1964, JAMA-J AM MED ASSOC, V187, P832

[2] BRILMAYER C, 1955, Z Krebsforsch, V60, P334, DOI 10.1007/BF00631687

[3] CLARKSON B, 1964, CANCER-AM CANCER SOC, V17, P914, DOI 10.1002/1097-0142(196407)17:7<914::AID-CNCR2820170712>3.0.CO

[4] 2-6

[5] GELLHORN A, 1961, DIS CHEST, V39, P165

[6] GOODMAN LS, 1956, PHARMACOL BASIS, P1167

[7] INHIBITION OF ENZYMES BY ATEBRIN [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1960, 44 (01) : 175 - 177

[8] HIRSCHBERG E, 1956, P AM ASSOC CANC RES, V2, P117

[9] SELECTION OF PATIENTS FOR EVALUTATION OF CHEMOTHERAPEUTIC PROCEDURES IN ADVANCED CANCER [J]. JOURNAL OF CHRONIC DISEASES, 1962, 15 (MAR): : 243 - &

[10] KURNICK NB, 1962, J LAB CLIN MED, V60, P669